Roper Technologies Announces $1.65 Billion CentralReach Acquisition, Targets 20%+ Growth

Zinger Key Points

Roper Technologies, Inc. ROP shares are trading higher on Monday after the company disclosed a deal to acquire CentralReach from Insight Partners for a net purchase price of around $1.65 billion.

The acquisition price factors in a $200 million tax benefit.

CentralReach offers cloud-based software designed to streamline the workflow and administration of Applied Behavior Analysis (ABA) therapy.

The platform also features AI-powered modules to enhance efficiency and care outcomes.

Roper plans to integrate CentralReach into its Application Software segment, with anticipated sustainable 20%+ organic revenue and EBITDA growth.

Notably, CentralReach is projected to generate around $175 million in revenue and $75 million in EBITDA for the 12 months ending June 30, 2026.

The acquisition, expected to close by April/May 2025, is subject to regulatory approval and customary conditions and will be financed through Roper’s revolving credit facility.

“This acquisition is another example of Roper identifying a business that provides greater value creation for our shareholders,” said Neil Hunn, Roper’s president and CEO.

”CentralReach meets each of our long-standing acquisition criteria, while also having a structurally faster organic growth profile and the ability to expand margins under Roper’s long-term ownership.”

As of FY24, the company had cash and equivalents of $188.2 million and net inventories worth $120.8 million.

Investors can gain exposure to the stock via Invesco Water Resources ETF PHO and Invesco Global Water ETF PIO.

Price Action: ROP shares are up 0.42% at $574.58 at the last check Monday.

Read Next:

Photo: Shutterstock

ROP Logo
ROPRoper Technologies Inc
$546.20-0.89%

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score
Edge Rankings
Momentum
68.85
Growth
81.38
Quality
38.16
Value
13.72
Price Trend
Short
Medium
Long
Got Questions? Ask
Which healthcare software companies could benefit from this acquisition?
How might Roper Technologies impact the ABA therapy market?
Which AI-driven firms stand to gain from CentralReach's technology?
What other cloud-based solutions may attract investment?
How will Roper's growth strategy affect its stock value?
Which investors should consider Roper's upcoming integration plans?
Could CentralReach's revenue boost Roper's overall market presence?
What implications does this have for regulatory approval processes?
How will this acquisition influence Roper's competitors in the tech sector?
Which ETFs may benefit from Roper's strategic moves?
Market News and Data brought to you by Benzinga APIs

Posted In:
Comments
Loading...